Flumatinib

• Description:

  Flumatinib is an orally bioavailable tyrosine kinase inhibitor flumatinib, with potential antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  562.6

• Molecular Formula:

  C29H29F3N8O

• Notes:

  Research use only, not for human use.

• Receptor:

  C-Abl|PDGFRβ|c-Kit|

• CAS Number:

  895519-90-1